Table 1.
Baseline Characteristics
| hsTnT <14 ng/L (n = 463) | hsTnT ≥14 ng/L (n = 3697) | P Value | |
|---|---|---|---|
| General characteristics | |||
| Age, y, mean | 60.3 | 64.1 | <0.0001 |
| Male, % | 58.3 | 70.5 | <0.0001 |
| Medical history | |||
| Hypertension, % | 70.5 | 72.2 | 0.43 |
| Hyperlipidemia, % | 59.4 | 56.6 | 0.25 |
| Smoker, % | 27.8 | 31.0 | 0.16 |
| DM, % | 26.5 | 31.9 | 0.017 |
| Previous MI, % | 19.3 | 26.5 | 0.0008 |
| Previous CHF, % | 4.5 | 8.1 | 0.007 |
| Presentation | |||
| Time from symptom onset, h | 13.2 | 13.2 | 0.89 |
| TIMI risk score, % | |||
| High | 15.2 | 35.9 | <0.0001 |
| Intermediate | 62.2 | 55.2 | |
| Low | 22.7 | 8.9 | |
| Therapy during hospitalization | |||
| Aspirin, % | 98.3 | 98.0 | 0.69 |
| β‐Blocker, % | 76.0 | 87.1 | <0.0001 |
| ACEI or ARB, % | 62.1 | 70.7 | 0.0002 |
| Statin, % | 82.5 | 85.5 | 0.09 |
| Heparin or LMWH, % | 46.8 | 73.4 | <0.0001 |
| Clopidogrel, % | 94.4 | 86.7 | <0.0001 |
| PCI, % | 48.8 | 59.7 | <0.0001 |
| CABG, % | 5.4 | 10.4 | 0.0007 |
Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; CABG, coronary artery bypass graft; CHF, congestive heart failure; DM, diabetes mellitus; hsTnT, high‐sensitivity cardiac troponin T; LMWH, low‐molecular‐weight heparin; MI, myocardial infarction; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in Myocardial Infarction.